S K Schimrigk

Summary

Country: Germany

Publications

  1. ncbi Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study
    S Schimrigk
    Department of Neurology, St Josef Hospital, Ruhr Universitat Bochum, Germany
    Eur J Neurol 13:604-10. 2006
  2. ncbi Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model
    S K Schimrigk
    Department of Neurology, St Josef Hospital, Ruhr University of Bochum, Bochum, Germany
    AJNR Am J Neuroradiol 28:724-30. 2007

Collaborators

Detail Information

Publications2

  1. ncbi Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study
    S Schimrigk
    Department of Neurology, St Josef Hospital, Ruhr Universitat Bochum, Germany
    Eur J Neurol 13:604-10. 2006
    ..Measures of T-cell function demonstrated alterations in cytokines and circulating tumor necrosis factor. The results of this exploratory study suggest that further studies of FAE in patients with MS are warranted...
  2. ncbi Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture model
    S K Schimrigk
    Department of Neurology, St Josef Hospital, Ruhr University of Bochum, Bochum, Germany
    AJNR Am J Neuroradiol 28:724-30. 2007
    ..A new method of measuring quantitative DTI parameters using a probabilistic mixture model for fiber tissue and background in the corticospinal tract of patients with ALS is evaluated. Materials and..